Ceftriaxone Export Market Intelligence: India's 850 Suppliers Shipping to 162 Countries — TransData Nexus 2026

Q: Who are the top ceftriaxone exporters from India?

The top ceftriaxone exporters from India are: 1. INNOVA CAPTAB LIMITED — $36.2M (12.7% market share); 2. UNIVENTIS MEDICARE LIMITED — $15.4M (5.4% market share); 3. UNILINK PHARMA PRIVATE LIMITED — $13.9M (4.9% market share); 4. AUROBINDO PHARMA LTD — $13.3M (4.6% market share); 5. MEDCELL PHARMA — $10.7M (3.7% market share). Together they account for 31.3% of India's total ceftriaxone export value.

Q: What is the total export value of ceftriaxone from India?

The total export value of ceftriaxone from India is $285.4M USD, recorded across 11,257 shipment transactions from 850 active exporters to 162 destination countries. The average shipment value is $25.4K.

Q: Which countries import ceftriaxone from India?

India exports ceftriaxone to 162 countries worldwide. The top importing countries are: KENYA (17.7% share, $50.6M), AFGHANISTAN (7.3% share, $20.9M), MEXICO (5.9% share, $16.7M), GUINEA (5.0% share, $14.1M), ETHIOPIA (4.6% share, $13.2M). These five markets account for 40.5% of total export value.

Q: What is the HS code for ceftriaxone exports from India?

The primary HS code for ceftriaxone exports from India is 30042019. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of ceftriaxone exports from India?

The average unit price for ceftriaxone exports from India is $3.73 USD per unit, with prices ranging from $0.00 to $914.87 depending on formulation, packaging, and order volume. The total market is valued at $285.4M across 11,257 shipments.

Q: Which ports handle ceftriaxone exports from India?

The primary ports for ceftriaxone exports from India are NHAVA SHEVA SEA (INNSA1) (10.7% of shipments), JNPT/ NHAVA SHEVA SEA (7.3% of shipments), JNPT (6.0% of shipments), SAHAR AIR CARGO ACC (INBOM4) (4.9% of shipments), DELHI AIR CARGO ACC (INDEL4) (4.2% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of ceftriaxone?

India is one of the world's leading exporters of ceftriaxone due to its large base of 850 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports ceftriaxone to 162 countries, demonstrating 83% global market coverage.

Q: What certifications do Indian ceftriaxone exporters need?

Indian ceftriaxone exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import ceftriaxone from India?

There are 2,555 registered buyers importing ceftriaxone from India, spread across 162 countries. The repeat buyer rate is 55.3%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top ceftriaxone supplier from India?

INNOVA CAPTAB LIMITED is the leading ceftriaxone exporter from India with a market share of 12.7% and total export value of $36.2M across 600 shipments. The top 5 suppliers together control 31.3% of total export value.

Suresh Sormare

Ceftriaxone

India Pharmaceutical Trade Intelligence

$285.4M850 Suppliers162 CountriesHS 30042019

ExportsIndia → KENYA17.7%India → AFGHANISTAN7.3%

ImportsIRAQ → India$50.2K UNITED ARAB → India$41.4K

#1 Supplier: INNOVA CAPTAB #1 Buyer: ROYAL PHARMA

Ceftriaxone Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Ceftriaxone to the World

Between 2022 and 2026, India exported $285.4M worth of ceftriaxone across 11,257 verified shipments to 162 countries — covering 83% of world markets in the Advanced Antibiotics segment. The largest destination is KENYA (17.7%). INNOVA CAPTAB LIMITED leads with a 12.7% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published May 2026·Updated May 2026·

Ceftriaxone export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Ceftriaxone export data snapshot — $285.4M · 850 exporters · 162 countriesTransData Nexus · Indian Customs Data

Top Ceftriaxone Exporters from India

850 active exporters · Ranked by export value

View all 850 →

Top Ceftriaxone Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	INNOVA CAPTAB LIMITED	$36.2M	600	20	12.7%
2	UNIVENTIS MEDICARE LIMITED

Top Countries Importing Ceftriaxone from India

162 destination markets · Ranked by import value

All 162 countries →

Top Countries Importing Ceftriaxone from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	KENYA	$50.6M	17.7%
2	AFGHANISTAN	$20.9M	7.3%
3	MEXICO	$16.7M	5.9%
4	GUINEA	$14.1M	5.0%
5	ETHIOPIA	$13.2M	4.6%
6	TURKEY	$11.8M	4.1%
7	YEMEN	$11.3M	4.0%
8	NIGERIA	$11.1M	3.9%
9	SUDAN	$10.2M	3.6%
10	PAKISTAN	$9.8M	3.4%

KENYA is India's largest ceftriaxone export destination, absorbing 17.7% of total exports worth $50.6M. The top 5 importing countries — KENYA, AFGHANISTAN, MEXICO, GUINEA, ETHIOPIA — together account for 40.5% of India's total ceftriaxone export value. The remaining 157 destination countries collectively receive the other 59.5%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Ceftriaxone to India?

4 origin countries · Total import value: $92.9K

India imports ceftriaxone from 4 countries with a combined import value of $92.9K. The largest supplier is IRAQ ($50.2K, 1 shipments), followed by UNITED ARAB EMIRATES and UNITED STATES. All values are from Indian Customs (DGFT) import records.

Countries Supplying Ceftriaxone to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	IRAQ	$50.2K	1	54.0%
2	UNITED ARAB EMIRATES	$41.4K	3	44.5%
3	UNITED STATES	$1.3K	5	1.4%
4	NETHERLANDS	$2	1	0.0%

IRAQ is the largest supplier of ceftriaxone to India, accounting for 54.0% of total import value. Click any country to see detailed supplier and buyer data for that import corridor.

Ceftriaxone — Export Intelligence Video

Visual overview of India's ceftriaxone import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's ceftriaxone pharmaceutical import and export market — $285.4M in total trade, 850 verified manufacturers, and 162 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Ceftriaxone

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, ceftriaxone is approved under multiple Abbreviated New Drug Applications (ANDAs), as listed in the FDA's Orange Book. These approvals attest to the drug's established safety and efficacy profiles. The regulatory pathway for ceftriaxone involves demonstrating bioequivalence to the reference listed drug, ensuring consistent therapeutic outcomes. Notably, the presence of 850 active Indian exporters highlights the competitive landscape and the importance of maintaining stringent quality standards to meet FDA requirements.

2EU & UK Regulatory Framework

In the European Union, ceftriaxone is subject to marketing authorization procedures overseen by the European Medicines Agency (EMA). Manufacturers must comply with EU Good Manufacturing Practice (GMP) guidelines to ensure product quality and safety. Similarly, in the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) regulates ceftriaxone, requiring adherence to national GMP standards. Compliance with these regulations is essential for market access and maintaining public health standards.

3WHO Essential Medicines & Global Standards

Ceftriaxone is included in the 24th edition of the WHO Model List of Essential Medicines, published in September 2025. This inclusion underscores its critical role in treating a wide range of bacterial infections. The drug is also listed in major pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), reflecting its global acceptance and standardized quality benchmarks.

4India Regulatory Classification

In India, ceftriaxone is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) has set a ceiling price for ceftriaxone to ensure affordability; however, the specific ceiling price and its effective date should be verified from the latest NPPA notifications. For exports, manufacturers must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT), ensuring compliance with national regulations and facilitating international trade.

5Patent & Exclusivity Status

The primary patents for ceftriaxone have expired, allowing for the production and export of generic versions. This has led to increased competition among manufacturers, contributing to the widespread availability and affordability of the drug in global markets.

6Recent Industry Developments

In May 2025, the WHO updated its Model List of Essential Medicines, reaffirming the inclusion of ceftriaxone, which highlights its continued importance in global health. In September 2025, the WHO published the 24th edition of the Model List of Essential Medicines, which includes ceftriaxone, underscoring its critical role in treating bacterial infections. (who.int)

These developments reflect the dynamic nature of the pharmaceutical industry and the ongoing efforts to ensure the availability and affordability of essential medicines like ceftriaxone.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Ceftriaxone

Retail & reference prices across 1 markets vs. India FOB export price of $3.73/unit

Global Price Benchmark for Ceftriaxone across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
Nigeria	Approximately $9.75 per vial	NGN	According to a 2025 report by the World Health Organization (WHO), the median retail price for a 1g vial of ceftriaxone injection in Nigeria was ₦3,570.00. (afro.who.int)

India Cost Advantage

India's pharmaceutical industry holds a significant cost advantage in the production of Active Pharmaceutical Ingredients (APIs) and finished formulations. This efficiency is largely attributed to well-established manufacturing clusters in Hyderabad, Ahmedabad, and Mumbai, which benefit from economies of scale and a skilled workforce. Additionally, the Pharmaceuticals Export Promotion Council of India (Pharmexcil) provides robust support to the industry, facilitating exports and ensuring compliance with international quality standards. *Note: Due to the limited availability of data on ceftriaxone 500 mg tablets, the above information pertains to the injectable form, which is more commonly used and documented.*

Supply Chain Risk Assessment — Ceftriaxone

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including the production of Ceftriaxone, heavily relies on Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs) imported from China. China controls approximately 70–80% of the global KSM supply and 60–70% of the global intermediate supply, making it a dominant player in the API sector. This dependency poses significant risks, as any disruption in Chinese supply chains can directly impact India's pharmaceutical manufacturing capabilities.

In December 2025, Delius Pharmaceuticals received approval from the Central Drugs Standard Control Organisation (CDSCO) to import Ceftriaxone Sodium API directly from China's Guangxi Kelun Pharmaceutical Co., Ltd. This move aims to enhance supply security and reduce reliance on local intermediaries. However, it also underscores the continued dependence on Chinese suppliers for critical antibiotic components.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five Indian exporters of Ceftriaxone account for 31.3% of total exports, with INNOVA CAPTAB LIMITED leading at a 12.7% share. This concentration suggests a moderate risk, as disruptions affecting these key suppliers could impact global supply chains.

To mitigate such risks, the Indian government has implemented the Production Linked Incentive (PLI) scheme, aiming to bolster domestic API production and reduce import dependence. In November 2024, two greenfield plants were inaugurated under this scheme to manufacture critical molecules used in common antibiotics. While this initiative is a positive step, its impact on reducing supplier concentration in the Ceftriaxone market remains to be seen.

Access Complete Ceftriaxone Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 11,257 transactions across 162 markets.

Request Demo View Pricing

Frequently Asked Questions — Ceftriaxone Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top ceftriaxone exporters from India?

The leading ceftriaxone exporters from India are INNOVA CAPTAB LIMITED, UNIVENTIS MEDICARE LIMITED, UNILINK PHARMA PRIVATE LIMITED, and 12 others. INNOVA CAPTAB LIMITED leads with 12.7% market share ($36.2M). The top 5 suppliers together control 31.3% of total export value.

What is the total export value of ceftriaxone from India?

The total export value of ceftriaxone from India is $285.4M, recorded across 11,257 shipments from 850 active exporters to 162 countries. The average shipment value is $25.4K.

Which countries import ceftriaxone from India?

India exports ceftriaxone to 162 countries. The top importing countries are KENYA (17.7%), AFGHANISTAN (7.3%), MEXICO (5.9%), GUINEA (5.0%), ETHIOPIA (4.6%), which together account for 40.5% of total export value.

What is the HS code for ceftriaxone exports from India?

The primary HS code for ceftriaxone exports from India is 30042019. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Ceftriaxone

Ceftriaxone

Top Ceftriaxone Exporters from India

Top Countries Importing Ceftriaxone from India

Who Supplies Ceftriaxone to India?

Quick Facts

Related Advanced Antibiotics

Related Analysis

Need Details?

Ceftriaxone — Export Intelligence Video

Regulatory Landscape — Ceftriaxone

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Ceftriaxone

India Cost Advantage

Supply Chain Risk Assessment — Ceftriaxone

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Ceftriaxone Trade Intelligence

Frequently Asked Questions — Ceftriaxone Exports from India

Who are the top ceftriaxone exporters from India?

What is the total export value of ceftriaxone from India?

Which countries import ceftriaxone from India?

What is the HS code for ceftriaxone exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of ceftriaxone exports from India?

Which ports handle ceftriaxone exports from India?

Why is India a leading exporter of ceftriaxone?

What certifications do Indian ceftriaxone exporters need?

How many buyers import ceftriaxone from India?

What is the market share of the top ceftriaxone exporter from India?

Analysis Methodology